Sequential antibiotic therapy

Netherlands Journal of Medicine

Volumn 50, Issue 3, 1997, Pages 93-96

  Mandell, L A ^a  

^a HENDERSON GENERAL HOSPITAL   (Canada)

Author keywords

Sequential antibiotic therapy

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; FLUCONAZOLE; METRONIDAZOLE;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; HEALTH ECONOMICS; HUMAN; INFECTION CONTROL; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; SHORT SURVEY;

EID: 0031044690     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(97)00002-8     Document Type: Article

References (31)

1. Feigin RD, Pickering LK, Anderson D, Keeney RE, Shackleford PG. Clindamycin treatment of osteomyelitis and septic arthritis in children. Pediatrics 1975;55:213-223.
2. Walker SH. Staphylococcal osteomyelitis in children. Success with cephaloridine-cephalexin therapy. Clin Pediatr 1973;12:98-100.
3. Tetzlaff TR, McCracken GH, Nelson JD. Oral antibiotic therapy for skeletal infections of children. II. Therapy of osteomyelitis and suppurative arthritis. J Pediatr 1978;92:485-490.
4. Bryson YJ, Connor JD, LeClerc M, Giammona ST. High-dose dicloxacillin treatment of acute staphylococcal osteomyelitis in children. J Pediatr 1979;94:673-675.
5. Prober CG, Yeager AS. Use of the serum bactericidal titer to assess the adequacy of oral antibiotic therapy in the treatment of acute hematogenous osteomyelitis. J Pediatr 1979;95:131-135.
6. Frighetto L, Nickoloff D, Martinusen SM, Mamdani FS, Jewesson PJ. Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital. Ann Pharmacother 1992;26:1447-1451.
7. Yogev R, Kolling WM, Williams T. Pharmacokinetic comparison of intravenous and oral chloramphenicol in patients with Haemophilus influenzae meningitis. Pediatrics 1981;67:656-660.
8. Grant SM, Clissold SP. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 1990;39:877-916.
9. Nightingale CH. Pharmacokinetic considerations in quinolone therapy. Pharmacotherapy 1993;13:34S-38S.
10. Hoffken G, Lode H, Prinzing C, Borner K, Koeppe P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother 1985;27:375-379.
11. Monk JP, Campoli-Richards DM. Ofloxacin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1987;33:346-391.
12. Rush DR. Antimicrobial formulary management: meeting the challenge in the community hospital. Pharmacotherapy 1991;11(1 Pt 2):19S-26S.
13. Plumridge RJ. Cost comparison of intravenous antibiotic administration. Med J Aust 1990;153:516-518.
14. Grasela TH Jr, Paladino JA, Schentag JJ, et al. Clinical and economic impact of oral ciprofloxacin as follow-up to parenteral antibiotics. DICP Ann Pharmacother 1991;25:857-862.
15. Paladino JA, Sperry HE, Backes JM, et al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med 1991;91:462-470.
16. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. J Am Med Assoc 1985;261:3273-3277.
17. Kalager T, Andersen BM, Bergan T, et al. Ciprofloxacin versus a tobramycin/cefuroxime combination in the treatment of serious systemic infections: a prospective, randomized and controlled study of efficacy and safety. Scand J Infect Dis 1992;24:637-646.
18. Dominguez J, Palma F, Vega ME, et al. Brief report: prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections. Am J Med 1989;87(suppl 5A):136S-137S.
19. Gaut PL, Carron WC, Ching WTW, Meyer RD. Intravenous/oral ciprofloxacin therapy versus intravenous ceftazidime therapy for selected bacterial infections. Am J Med 1989;87(suppl 5A):169S-175S.
20. Fass RJ, Plouffe JF, Russell JA. Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections. Am J Med 1989;87(suppl 5A):164S-168S.
21. Cox CE. Brief report: sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections. Am J Med 1989;87(suppl 5A):157S-159S.
22. Hirata-Dulas CAI, Stein DJ, Guay DRP, Gruninger RP, Peterson PK. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. J Am Geriatr Soc 1991;39:979-985.
23. Khan FA, Basir R. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections. Chest 1989;96:528-537.
24. Menon L, Ernst JA, Sy ER, Flores D, Pacia A, Lorian V. Brief report: sequential intravenous/oral ciprofloxacin compared with intravenous ceftazidime in the treatment of serious lower respiratory tract infections. Am J Med 1989;87(suppl 5A):119S-120S.
25. Peacock JE, Pegram PS, Weber SF, Leone PA. Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections. Am J Med 1989;87(suppl 5A):185S-190S.
26. Gangji D, Jacobs F, de Jonckheer J, et al. Brief report: randomized study of intravenous versus sequential intravenous/oral regimen of ciprofloxacin in the treatment of gram-negative septicemia. Am J Med 1989;87(suppl 5A):206S-208S.
27. Feist H. Sequential therapy with I.V. and oral ofloxacin in lower respiratory tract infections: a comparative study. Infection 1991;19(suppl 7):380-383.
28. Khajotia R, Drlicek M, Vetter N. A comparative study of ofloxacin and amoxycillin/clavulanate in hospitalized patients with lower respiratory tract infections. J Antimicrob Chemother 1990;26(suppl D):83-91.
29. Johnson JR, Lyons MF, Pearce W, et al. Therapy for women hospitalized with acute pyelonephritis: a randomized trial of ampicillin versus trimethoprim-sulfamethoxazole for 14 days. J Infect Dis 1991;163:325-330.
30. Mandell LA, Bergeron MG, Gribble MJ, et al. Sequential antibiotic therapy: effective cost management and patient care. Can J Infect Dis 1995;6:306-315.
31. Department of Clinical Epidemiology and Biostatistics, McMaster University Health Sciences Centre. How to read clinical journals. V. To distinguish useful from useless or even harmful therapy. Can Med Assoc J 1981;124:1156-1162.